Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium two pore domain channel subfamily K member 15 (KCNK15, also known as TASK-5) is a member of the two pore domain potassium (K2P) channel family. While isolated KCNK15 (TASK-5) subunits do not form functional homomeric channels, they can form heteromeric channel complexes with TASK-1 and TASK-3, which then display unique electrophysiological and pharmacological properties. These heterodimers are found in various tissues, including the heart, vascular smooth muscle, pancreas, liver, lung, ovary, and testis. TASK-5 modulates the cell surface expression and function of TASK-1 and TASK-3 channels. Its unique association with physiological and disease processes, especially in cardiovascular disease, cancer, and sleep apnea, suggests emerging relevance as a therapeutic target, though there are currently no approved drugs targeting KCNK15 specifically. Key facts: - Not a functional potassium channel as a homodimer; requires co-assembly with TASK-1 or TASK-3 for activity. - Co-expression alters channel surface expression, conductance, and responsiveness to pharmacological modulators. - Genetic polymorphisms in KCNK15 may serve as biomarkers for patient stratification in TASK channel-targeted therapy.
Modulation of potassium channel function via heteromeric complex formation (with TASK-1/TASK-3) can affect the pharmacological response and channel conductance properties. Gq-coupled receptor-mediated inhibition of heteromeric channels may be altered.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium two pore domain channel subfamily K member 15 (KCNK15).